Skip to main content
Table of Contents
Print

Can Cannabis Act as Relapse Prophylaxis Post-Therapy for Depression? 

Author: Dr. Clarissa Morton, PharmD

The possibility of using cannabis as relapse prophylaxis for depression  is a growing area of interest, especially for patients who have completed therapy but remain vulnerable to future episodes. Relapse is common in depression, and ongoing strategies are often required to maintain stability. Some early findings suggest cannabinoids, particularly CBD, may support maintenance treatment by reducing stress, improving sleep, and stabilising mood. 

However, the evidence is still preliminary. While some individuals find cannabis beneficial in maintaining balance, long-term use, especially with THC, can increase risks of dependency or emotional blunting. 

Cannabis And Preventive Strategies 

Research into cannabis as relapse prophylaxis for depression explores whether cannabinoids can play a role in follow-up care after successful therapy. 

Maintenance Treatment 

CBD’s calming and anti-anxiety properties may provide a form of maintenance treatment, helping patients stay emotionally balanced between episodes. 

Therapy Follow-Up 

Cannabis might also support therapy follow-up, making it easier for patients to manage residual symptoms such as insomnia or tension, which can otherwise trigger relapse. 

Preventive Care 

By supporting sleep, stress regulation, and daily resilience, cannabis may offer preventive care benefits. Still, its role should be considered complementary rather than a substitute for established approaches. 

In summary, while early evidence suggests cannabis as relapse prophylaxis for depression could be a useful adjunct, more clinical trials are needed to confirm its effectiveness and safety in long-term prevention. 

For patients considering cannabis as part of their post-therapy plan, providers like LeafEase can offer supportive consultations tailored to safe and personalised preventive care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories